bell
The current prices are delayed by 15 mins, login to check live prices.
Beryl Drugs Ltd share price logo

Beryl Drugs Ltd

(524606)

₹32.671.15%

as on 04:01PM, 22 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Beryl Drugs Ltd Performance

  • Day's Low

    Day's High

    ₹32.35
    ₹34.2
  • 52 Week's Low

    52 Week's High

    ₹19.51
    ₹46
1 Month Return-12.17 %
3 Month Return+ 1.3 %
1 Year Return+ 62.21 %
Previous Close₹32.30
Open₹32.35
Volume654.00
Upper Circuit-
Lower Circuit-
Market Cap₹16.38Cr

Beryl Drugs Ltd Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹16.38 Cr
P/B Ratio1.67
EPS0
Dividend Yield0
SectorPharmaceuticals
ROE9.07

Beryl Drugs Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹16.38 Cr101.97%0.69NANA
NA₹44.02 Cr1.53%0.58NANA
NA₹260.52 Cr273.93%0.58-₹12 Cr₹15 Cr
NA₹286.75 Cr122.28%0.66₹5 Cr₹155 Cr
NA₹15,763.63 Cr26.32%0.51NANA

About Beryl Drugs Ltd

Beryl Drugs Ltd is a leading generic pharmaceutical manufacturing company based in Indore, India, providing a range of branded and generic formulations, I.V.fluids, a range of small and large volume injectables, eye/ear drops, veterinary products and injections. Established in 1993, with operations taken over from M/s Flora and Fauna Remedies, Beryl Drugs have successfully set up a global network of pharmaceutical manufacturing research and development, contract manufacturing services, and veterinary products. The company is in compliance with WHO GMP specifications, and has also achieved ISO 9001:2000 certification for their quality management. Beryl Drugs are popular for many of their branded products like BERICEF injection, FNeuron Amplicillin INJ, PMol Biprox, BFlox and many more.

Share Price: ₹32.67 per share as on 22 Nov, 2024 04:01 PM
Market Capitalisation: ₹16.38Cr as of today
Chairperson Name: Sudhir Sethi
OrganisationBeryl Drugs Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Beryl Drugs Ltd

  • Beryl Drugs Shares Gain 1% During Trading Session - 20 Feb, 2024

    Beryl Drugs Ltd shares started trading at Rs. 39.99 and hit a high of Rs. 40.99, gaining around 1%. The company's revenue decreased by 5%, but net profits increased by 15% in the December quarter. Beryl Drugs has delivered a multibagger of 212% to investors in one year.

Insights on Beryl Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Beryl Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 73.62% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 26.38% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 62.6% return, outperforming this stock by 0.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, Beryl Drugs stock has moved down by -12.2%

Beryl Drugs Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹18.78Cr (-)₹18.10Cr (↓3.62%)₹17.80Cr (↓1.66%)₹17.68Cr (↓0.67%)
Total Liabilities₹10.85Cr (-)₹10.81Cr (↓0.37%)₹9.74Cr (↓9.90%)₹8.76Cr (↓10.06%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹0.18Cr (-)₹0.34Cr (↑88.89%)-₹0.29Cr (↓185.29%)₹2.39Cr (↓924.14%)₹0.82Cr (↓65.69%)
0

Beryl Drugs Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
26.38%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
73.62%
0.00
Others
0%
0.00

Beryl Drugs Ltd Key Indicators

Details20202021202220232024
Return On Equity %0.66-1.29-8.6710.039.07

Beryl Drugs Ltd Earnings and Dividends

  • Beryl Drugs Ltd Earnings Results

    Beryl Drugs Ltd’s net profit fell -96.3% since last year same period to ₹0.01Cr in the Q2 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated -97.3% fall in its net profits since last 3-months.

    Read More about Earnings Results

Beryl Drugs Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Beryl Drugs Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Beryl Drugs Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Beryl Drugs Ltd shares.

Beryl Drugs Ltd (524606) share price today is ₹32.67

Beryl Drugs Ltd is not listed on NSE

Beryl Drugs Ltd is listed on BSE

  • Today’s highest price of Beryl Drugs Ltd is ₹34.2.
  • Today’s lowest price of Beryl Drugs Ltd is ₹32.35.

Today’s traded volume of Beryl Drugs Ltd(524606) is 654.00.

Today’s market capitalisation of Beryl Drugs Ltd(524606) is ₹16.38Cr.

Beryl Drugs Ltd(524606Price
52 Week High
₹46
52 Week Low
₹19.51

Beryl Drugs Ltd(524606) share price is ₹32.67. It is down -28.98% from its 52 Week High price of ₹46

Beryl Drugs Ltd(524606) share price is ₹32.67. It is up 67.45% from its 52 Week Low price of ₹19.51

Beryl Drugs Ltd(524606Returns
1 Day Returns
0.37%
1 Month Returns
-12.17%
3 Month Returns
1.3%
1 Year Returns
62.21%